References
1. Alaev D.S., Kotova I.V. Nephrolithiasis in primary hyperparathyroidism. Al’manakh klinicheskoy meditsiny [Almanac of Clinical Medicine]. 2016; (28): 58-60. DOI: https://doi.org/10.18786/2072-0505-2013-28-58-60 (in Russian)
2. Alaev D.S., Kotova I.V. Persistent primary hyperparathyroidism. Al’manakh klinicheskoy meditsiny [Almanac of Clinical Medicine]. 2012; (26): 56-9. (in Russian)
3. Bilezikian J.P., Khan A.A., Potts J.T. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab. 2009; 94 (2): 335-9. DOI: https://doi.org/10.1210/jc.2008-1763
4. Bilezikian J.P., Brandi M.L., Eastell R., et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the fourth international workshop. J Clin Endocrinol Metab. 2014; 99 (10): 3561-9. DOI: https://doi.org/10.1210/jc.2014-1413
5. AACE/AAES Task force on primary hyperparathyroidism. The American Association of Clinical Endocrinologists and the American Association of Endocrine Surgeons position statement on the diagnosis and management of primary hyperparathyroidism. Endocr Pract. 2005; 11 (1): 49-54. DOI: https://doi.org/10.4158/ep.11.1.49
6. van Dalen A., Smit C.P., van Vroonhoven T.J., Burger H., de Lange E.E. Minimally invasive surgery for solitary parathyroid adenomas in patients with primary hyperparathyroidism: role of US with supplemental CT. Radiology. 2001; 220 (3): 631-9. DOI: https://doi.org/10.1148/radiol.2203000998
7. Bilezikian J.P., Meng X., Shi Y., Silverberg S.J. Primary hyperparathyroidism in women: New York and Beijing (a Tale of Two Cities). Int J Fertil Womens Med. 2000; 45: 158-65.
8. Hedback G., Oden A. Recurrence of hyperparathyroidism, along-term follow - up after surgery for primary hyperparathyroidism. Eur J Endocrinol. 2003; 148 (5): 413-21.
9. Broadus A.E., Horst R.L., Littledike E.T., Mahaf-fey J.E. Primary hyperparathyroidism with intermittent hypercalcaemia: serial observations and simple diagnosis by means of an oral calcium tolerance test. Clin Endocrinol (Oxf). 1980; 12: 225-35.
10. Adler J.T., Sippel R.S., Schaefer S., Chen H. Surgery improves quality of life in patients with «mild» hyperparathyroidism. Am J Surg. 2009; 197 (3): 284-90. DOI: https://doi.org/10.1016/j.amjsurg.2008.09.009
11. Brito K., Edirimanne S., Eslick G.D. The extent of improvement of healthrelated quality of life as assessed by the SF36 and Paseika scales after parathyroidectomy in patients with primary hyperparathyroidism - a systematic review and meta-analysis. Int J Surg. 2015; 13: 245-9. DOI: https://doi.org/10.1016/j.ijsu.2014.12.004
12. Caillard C., Sebag F., Mathonnet M., et al. Prospective evaluation of quality of life (SF-36v2) and nonspecific symptoms before and after cure of primary hyperparathyroidism (1-year follow-up). Surgery. 2007; 141 (2): 153-60. DOI: https://doi.org/10.1016/j.surg.2006.12.004
13. Ryhanen E., Heiskanen I., Sintonen H., et al. Health-related quality of life is impaired in primary hyperparathyroidism and significantly improves after surgery: a prospective study using the 15D instrument. Endocr Connect. 2015; 4 (3): 179-86.
14. Ejlsmark-Svensson H., Sikjaer T., Webb S.M., et al. Health-related quality of life improves 1 year after parathyroidectomy in primary hyperparathyroidism: a prospective cohort study. Clin Endocrinol (Oxf). 2019; 90 (1): 184-91. DOI: https://doi.org/10.1111/cen.13865
15. Norman J., Lopez J., Politz D. Abandoning unilateral parathyroidectomy: why we reversed our position after 15,000 parathyroid operations. J Am Coll Surg. 2012; 214: 260-9.
16. Teksoz S., Bukey Y., Ozcan M., Arikan A.E., et al. Minimal invasive parathyroidectomy with local anesthesia for well-localized primary hyperparathyroidism: «Cerrahpasa experience». Updates Surg. 2013; 65 (3): 217-23.